Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABCSG-18: Denosumab in AI-treated Breast Cancer
NCT00556374Phase 3Completed
- Sponsor
- Amgen
- Start
- Dec 2006
- Primary completion
- Oct 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of denosumab in breast cancer, sponsored by Amgen. Started Dec 2006; status: completed.
02
Drugs
denosumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00556374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00556374.